It's a major step back from statements made at a White House news conference in September, when President Donald Trump and ...

GSK has reached a near-$1bn deal to acquire 35Pharma, a Canadian biotech that develops drugs for heart and lung diseases, as part of a drive to replenish its pipeline with relatively inexpensive ...

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism ...

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration ...

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

GSK beat profit expectations in the fourth quarter, driven by demand for its HIV drugs and Asthma medicine. The pharmaceutical giant reported 8 per cent sales growth to £13.5billion, driven by a 17 ...

March 9 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.

Researchers at the University of Toronto have developed LUMI-lab, an AI-enabled self-driving laboratory that has identified brominated lipid tails as a potent and previously unrecognised enhancer ...

Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits, fuelled by HIV, cancer and respiratory medicines. A buoyant fourth quarter saw an ...

GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now. On February 4, GSK plc (NYSE:GSK) announced fourth-quarter earnings that outperformed analyst estimates in several ...